FRA16D |
|
fragile site, aphidicolin type, common, fra(16)(q23.2)
|
|
|
0.656 |
0.577 |
HTC2 |
|
hypertrichosis 2 (generalized, congenital)
|
|
|
0.392 |
0.808 |
PTMAP4 |
|
prothymosin alpha pseudogene 4
|
|
|
0.638 |
0.731 |
SAI1 |
|
suppression of anchorage independence 1
|
|
|
0.560 |
0.615 |
SEA |
|
S13 erythroblastosis (avian) oncogene homolog
|
|
|
0.606 |
0.615 |
TERC |
|
telomerase RNA component
|
|
|
0.471 |
0.846 |
UGT1A |
|
UDP glucuronosyltransferase family 1 member A complex locus
|
|
|
0.540 |
0.654 |
KCNQ1OT1 |
|
KCNQ1 opposite strand/antisense transcript 1
|
|
|
0.534 |
0.731 |
PTENP1 |
|
phosphatase and tensin homolog pseudogene 1
|
|
|
0.650 |
0.577 |
PART1 |
|
prostate androgen-regulated transcript 1
|
|
|
0.483 |
0.885 |
TUG1 |
|
taurine up-regulated 1
|
|
|
0.522 |
0.769 |
TP73-AS1 |
|
TP73 antisense RNA 1
|
|
|
0.599 |
0.577 |
FRTS1 |
|
Fanconi renotubular syndrome
|
|
|
0.599 |
0.654 |
FOXD2-AS1 |
|
FOXD2 adjacent opposite strand RNA 1
|
|
|
0.644 |
0.423 |
ANIB1 |
|
aneurysm, intracranial berry 1
|
|
|
0.608 |
0.500 |
CASC2 |
|
cancer susceptibility 2
|
|
|
0.612 |
0.462 |
H19 |
|
H19 imprinted maternally expressed transcript
|
|
|
0.494 |
0.923 |
NEAT1 |
|
nuclear paraspeckle assembly transcript 1
|
|
|
0.502 |
0.769 |
LINC00319 |
|
long intergenic non-protein coding RNA 319
|
|
|
0.711 |
0.385 |
MALAT1 |
|
metastasis associated lung adenocarcinoma transcript 1
|
|
|
0.435 |
0.846 |
LINC00511 |
|
long intergenic non-protein coding RNA 511
|
|
|
0.638 |
0.423 |
LINC01194 |
|
long intergenic non-protein coding RNA 1194
|
|
|
0.470 |
0.769 |
MIRLET7E |
|
microRNA let-7e
|
|
|
0.592 |
0.769 |
MIR100 |
|
microRNA 100
|
|
|
0.521 |
0.846 |
MIR106A |
|
microRNA 106a
|
|
|
0.524 |
0.846 |